We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Non-Invasive Process Determines Blood Glucose Levels Without Sample

By LabMedica International staff writers
Posted on 03 Oct 2022
Print article
Image: New non-invasive blood glucose monitoring process could put an end to painful pricks to draw blood (Photo courtesy of Pexels)
Image: New non-invasive blood glucose monitoring process could put an end to painful pricks to draw blood (Photo courtesy of Pexels)

Diabetics are often required to prick their finger several times a day to draw blood and check their glucose levels using an electronic monitor. Researchers have been working on working on improving the glucose monitoring process for the millions of people around the world affected by diabetes by making it less invasive and painful. Now, a team of researchers has created a non-invasive process that can identify the exact value of blood glucose with 90% accuracy without taking a blood sample.

The GlucoCheck process developed by researchers at Kennesaw State University (Kennesaw, GA, USA) uses light shone through human tissue, in either the ear or finger, and a small camera to capture images on the other side. The team then uses a model to study the amount of light absorption in those images to determine blood glucose concentration. The team has filed a provisional patent application with the U.S. Patent and Trademark Office to protect the process they have created. The researchers have tested the process on nearly 50 people so far, but before filing a full patent next summer, they will assess how the process works on people with a range of skin pigmentations and skin thickness. The team has already created a mobile phone application and is working on connecting GlucoCheck to Amazon’s virtual assistant, Alexa.

“Our pilot study was very successful. We are excited about how this device will help people with diabetes, which affects about one in every 10 people in the United States,” said Maria Valero, assistant professor of information technology in Kennesaw State’s College of Computing and Software Engineering (CCSE). “The way we gather and output the data is novel, and we will continue to work on ways to improve the glucose estimation model.”

Related Links:
Kennesaw State University 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article


Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more


view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more


view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more


view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.